Thirumalai Chemicals reported a significant increase in consolidated losses for FY26 to ₹167.91 crore, up from ₹46.10 crore in FY25. Revenue also declined, citing weak global demand and pricing pressures.
Thirumalai Chemicals Posts Wider FY26 Consolidated Loss of ₹167.91 Crore
Thirumalai Chemicals Ltd. has reported a significant increase in its consolidated net loss for the financial year 2025-26, reaching ₹167.91 crore, a substantial rise from the ₹46.10 crore loss recorded in the previous fiscal year.
Reader Takeaway: Wider losses and covenant breaches signal challenges amid weak demand; US asset ramp-up is a key future driver.
What just happened
Thirumalai Chemicals reported a standalone revenue of ₹1,393.28 crore and a net loss of ₹65.40 crore for FY26. On a consolidated basis, revenue stood at ₹1,754.23 crore, with the net loss widening to ₹167.91 crore. This contrasts with FY25's standalone revenue of ₹2,183.27 crore and profit of ₹82.21 crore, and consolidated revenue of ₹2,070.11 crore and loss of ₹46.10 crore.
The company's standalone EBITDA also saw a sharp decline to ₹20.13 crore from ₹182.89 crore, while consolidated EBITDA turned negative at ₹16.45 crore, compared to a profit of ₹69.40 crore in FY25.
Why this matters
The widening losses and declining revenues underscore the challenging market conditions faced by Thirumalai Chemicals. The breach of financial covenants raises concerns about the company's short-term financial health and its ability to service debt, which could impact investor sentiment and access to further financing.
The backstory
Thirumalai Chemicals is in a period of significant capital expenditure and expansion, particularly with its US-based assets. This growth phase, coupled with weak global demand and geopolitical tensions affecting the chemical industry, has impacted profitability.
What changes now
The company's board has decided not to declare a dividend for FY26, reflecting the current financial performance. The appointment of new statutory auditors, PKF Sridhar & Santhanam LLP, for a five-year term is a routine corporate governance step.
Risks to watch
- Financial Covenants: A key concern is the breach of financial covenants as of March 31, 2026, for which waivers were obtained. The company has expressed uncertainty regarding meeting covenants for September 2026 and March 2027.
- Market Headwinds: Persistent weak global demand, trade barriers, and volatile raw material prices continue to pose external risks.
What Looks Positive
Despite the current financial pressures, the Dahej facility has achieved 100% capacity utilization. The company anticipates FY27 to be crucial for stabilizing and growing its US-based assets.
What This Means for Investors
Shareholders should focus on the company's ability to manage its debt, secure waivers for loan covenants, and successfully scale up operations at its new domestic and US facilities. The turnaround in profitability hinges on global demand recovery and operational efficiency.
Investor Takeaway
Thirumalai Chemicals faces significant financial challenges during its expansion phase, marked by wider losses and covenant breaches. While management aims for cost leadership and stabilization of new assets, near-term outlook is tied to global economic conditions. Tracking US subsidiary debt refinancing and covenant compliance is crucial for investors.